Peter Fitzgerald Ph.D Overview
- Company
- HeartBeam
- Primary Position
-
Chief Medical Of...
- Primary Industry
-
Healthcare
- Active Board Seats
-
6
- Med. Deal Size
-
- Med. Valuation
-
Peter Fitzgerald Ph.D General Information
Biography
Dr. Peter Fitzgerald serves as Chief Medical Officer & Member of the Scientific Advisory Board at HeartBeam. He is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory at Stanford University Medical School. He is an interventional cardiologist and holds a PhD in Electrical Engineering. He is a Professor Emeritus in the Department of Medicine (Cardiology) at Stanford University. Over the past two decades, he has trained post-doctoral candidates in engineering and medicine. He served as a Medical Venture Partner at BioStar Capital. He has been the principal and Founder of 24 medical device companies in the San Francisco Bay area, transitioning 18 of these start-ups to medium/large-cap life science companies. In 2009, he co-founded TriVentures, an Israeli-based incubator/venture fund for early-stage medical technology and digital health. He has also been a consultant to the US Food and Drug Administration for the past 20 years, focused on medical technology and data-driven health analytics.
Contact Information
Address
- 2118 Walsh Avenue
- Suite 210
- Santa Clara, CA 95050
- United States
Peter Fitzgerald Ph.D Positions (5)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
HeartBeam | Company | Chief Medical Officer & Member of Scientific Advisory Board | Santa Clara, CA | Diagnostic Equipment | |
Latterell Venture Partners | Investor | Venture Consultant | San Ramon, CA | Venture Capital | |
PNI Digital Media | Company | Chairman | Vancouver, Canada | Business/Productivity Software | |
TransPacific Venture Partners | Investor | Managing Director | Taipei City, Taiwan | Venture Capital | |
Triventures | Investor | Co-Founder & Managing Partner | Herzliya, Israel | Venture Capital |
Peter Fitzgerald Ph.D Board Seats (6)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
19Labs | Diagnostic Equipment | Privately Held (backing) | Venture Capital-Backed | Redwood City, CA | |
Colospan | Surgical Devices | Privately Held (backing) | Venture Capital-Backed | Kfar Saba, Israel | |
Day Zero Diagnostics | Diagnostic Equipment | Privately Held (backing) | Venture Capital-Backed | Boston, MA | |
Genoox | Enterprise Systems (Healthcare) | Privately Held (backing) | Private Equity-Backed | Palo Alto, CA | |
PNI Digital Media | Business/Productivity Software | Acquired/Merged (Operating Subsidiary) | Formerly VC-backed | Vancouver, Canada |
Peter Fitzgerald Ph.D Lead Partner on Deals (24)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Day Zero Diagnostics | 09-Feb-2022 | Later Stage VC (Series A1) | Completed | Diagnostic Equipment | Boston, MA | |
Genoox | 01-May-2021 | Completed | Enterprise Systems (Healthcare) | Palo Alto, CA | ||
V-Wave | 22-Sep-2020 | Completed | Therapeutic Devices | Caesarea, Israel | ||
Cala Health | 21-May-2019 | Completed | Therapeutic Devices | San Mateo, CA | ||
CathWorks | 04-Feb-2019 | Completed | Decision/Risk Analysis | Kfar-Saba, Israel | ||
Day Zero Diagnostics | 20-Dec-2018 | Completed | Diagnostic Equipment | Boston, MA | ||
Somnics | 02-Oct-2018 | Completed | Therapeutic Devices | Zhubei, Taiwan | ||
19Labs | 04-Jun-2018 | Completed | Diagnostic Equipment | Redwood City, CA | ||
Genoox | 15-May-2018 | Early Stage VC (Series B) | Completed | Enterprise Systems (Healthcare) | Palo Alto, CA | |
CathWorks | 02-Oct-2017 | Early Stage VC (Series B) | Completed | Decision/Risk Analysis | Kfar-Saba, Israel |
Peter Fitzgerald Ph.D Network (158)
Board Members (73)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Scott Ward | Apica Cardiovascular | Self | Galway, Ireland | |
Scott Ward | CathWorks | Self | Kfar-Saba, Israel | |
Colospan | Clal Biotechnology Industries | Kfar Saba, Israel | ||
Stem Cell Theranostics | Self | Redwood City, CA | ||
OrthoSpace | HealthpointCapital | Caesarea, Israel |
Portfolio Executives (70)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Jeremy Parrish | Day Zero Diagnostics | Senior Director of Finance & Operations | 09-Feb-2022 | Boston, MA |
Dougal Maclaurin Ph.D | Day Zero Diagnostics | Scientific Co-Founder | 09-Feb-2022 | Boston, MA |
Day Zero Diagnostics | Scientific Co-founder | 09-Feb-2022 | Boston, MA | |
Day Zero Diagnostics | Co-Founder & Chief Technology Officer | 09-Feb-2022 | Boston, MA | |
Day Zero Diagnostics | Co-Founder & Chief Scientific Officer | 09-Feb-2022 | Boston, MA |
Fund Team Members (15)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Orli Tori | Triventures | Triventures IV Fund | Herzliya, Israel |
Stephen Salmon | Latterell Venture Partners | Latterell Venture Partners III | San Ramon, CA |
Latterell Venture Partners | San Ramon, CA | ||
BioStar Capital | Charlevoix, MI | ||
BioStar Capital | Charlevoix, MI |
Peter Fitzgerald Ph.D Affiliated Funds (6)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
BioStar Ventures II | BioStar Capital | Venture - General | Closed | 2008 | ||||
Triventures III Fund | Triventures | Venture - General | Closed | 2015 | ||||
BioStar Ventures III | BioStar Capital | Venture - General | Closed | 2013 | ||||
Triventures IV Fund | Triventures | Venture - General | Closed | 2019 | ||||
TransPacific Medtech Fund | TransPacific Venture Partners | Venture - General | Closed | 2014 |
Peter Fitzgerald Ph.D Advisory Roles (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Teal Ventures | Investor | Advisor | San Diego, CA | Venture Capital |
Peter Fitzgerald Ph.D FAQs
-
Who is Peter Fitzgerald Ph.D?
Dr. Peter Fitzgerald serves as Chief Medical Officer & Member of the Scientific Advisory Board at HeartBeam.
-
How much does Peter Fitzgerald Ph.D typically invest?
Peter Fitzgerald Ph.D's median deal size is
. -
What is Peter Fitzgerald Ph.D’s main position?
Peter Fitzgerald Ph.D’s primary position is Chief Medical Officer & Member of Scientific Advisory Board.
-
What are the contact details for Peter Fitzgerald Ph.D?
Peter Fitzgerald Ph.D’s email address is pe
and his phone number is +1 (408) . -
How many active board seats does Peter Fitzgerald Ph.D hold?
Peter Fitzgerald Ph.D holds 6 board seats including 19Labs, Colospan, Day Zero Diagnostics, Genoox, and PNI Digital Media.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »